GILD34
Gilead Sciences Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh · BMFBOVESPA:GILD34
84.00 BRL10.01 +13.53%
Gilead Sciences Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh (BMFBOVESPA:GILD34) last traded at 84.00 BRL, up 13.53% on the day. Over the past year the stock is up 56.78%. Its 52-week range is 52.08 to 84.00. It is in the Health Technology sector (Biotechnology).
Key statistics
Open77.70
Day range77.70 – 84.00
52-week range52.08 – 84.00
Volume8
Average volume (10 days)191
Market cap (USD)211.64 B
EPS (TTM) (USD)−0.000231
Dividend yield1.13%
Beta (1 year)−0.6616
Revenue (TTM) (USD)31.16 B
Employees17.00 K
Performance
+27.12%1 week
+27.39%1 month
+52.79%3 months
+56.96%6 months
+58.62%Year to date
+56.78%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
- Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.